Cluster 1 - Health (Single stage - 2027/1)

Development of innovative antimicrobials against pathogens resistant to antimicrobials

Tools and technologies to support health adaptation to climate change

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Addressing disabilities through the life course to support independent living and inclusion

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

Prevention and management of chronic non-communicable diseases in children and young people (GACD)